[1] Emberson, J. et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials. The Lancet 384, 1929–1935 (2014).
[2] Aguiar de Sousa, D. et al. Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries. European Stroke Journal 4, 13–28 (2019). URL https://www.ncbi.nlm.nih.gov/pmc/artic les/PMC6533860/.
[3] Allen, M. et  al. Using simulation and machine learning to maximise the benefit of intravenous thrombolysis in acute stroke in England and Wales: the SAMueL modelling and qualitative study. Health and Social Care Delivery Research 10, 1–148 (2022). URL https://www.journalslibrary.nihr.ac.uk/hsdr/GVZL5699/.
[4] Allen, M. et al. Use of Clinical Pathway Simulation and Machine Learning to Identify Key Levers for Maximizing the Benefit of Intravenous Thrombolysis in Acute Stroke. Stroke 53, 2758–2767 (2022). URL https://www.ahajournals.org/doi/10.1161/STROKEAH A.121.038454. Publisher: American Heart Association.
[5] Carter-Jones, C. R. Stroke thrombolysis: Barriers to implementation. International Emergency Nursing 19, 53–57 (2011).
[6] Kamal, N. et al. Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get with the Guidelines. Stroke 48, 946–954 (2017). Number: 4.
[7] Lahr, M. M. H., Luijckx, G.-J., Vroomen, P. C. A. J., van der Zee, D.-J. & Buskens, E. Proportion of patients treated with thrombolysis in a centralized versus a decentralized acute stroke care setting. Stroke 43, 1336–1340 (2012).
[8] Morris, S. et al. Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis. Bmj 349, g4757–g4757 (2014). URL http://www.bmj.com/cgi/doi/10.1136/bmj.g4757.
[9] Hunter, R. M. et al. Impact on clinical and cost outcomes of a centralized approach to acute stroke care in London: a comparative effectiveness before and after model. PloS One 8, e70420 (2013).
[10] De Bru´n, A. et al. Factors that influence clinicians’ decisions to offer intravenous alteplase in acute ischemic stroke patients with uncertain treatment indication: Results of a discrete choice experiment. International Journal of Stroke 13, 74–82 (2018). URL https://doi.org/10.1177/1747493017690755. Publisher: SAGE Publications.
[11] Pearn, K. et al. What would other emergency stroke teams do? Using explainable machine learning to understand variation in thrombolysis practice. European Stroke Journal 23969873231189040 (2023). URL https://doi.org/10.1177/23969873231189040..
[12] Aas, K., Jullum, M. & Løland, A. Explaining individual predictions when features are dependent: More accurate approximations to Shapley values (2020). URL http://arxiv.org/abs/1903.10464. Number: arXiv:1903.10464 arXiv:1903.10464 [cs, stat].
[13] Tennant, P. W. G. et al. Use of directed acyclic graphs (DAGs) to identify confounders in applied health research: review and recommendations. International Journal of Epidemiology 50, 620–632 (2021). URL https://doi.org/10.1093/ije/dyaa213.
[14] Bigirumurame, T. et al. Current practices in studies applying the target trial emulation framework: a protocol for a systematic review. BMJ Open 13, e070963 (2023). URL https://bmjopen.bmj.com/content/13/6/e070963. Publisher: British Medical Journal Publishing Group Section: Research methods.
[15] Craig, P., Katikireddi, S. V., Leyland, A. & Popham, F. Natural Experiments: An Overview of Methods, Approaches, and Contributions to Public Health Intervention Research. Annual Review of Public Health 38, 39–56 (2017).
[16] Igelstr¨om, E. et al. Causal inference and effect estimation using observational data. J Epidemiol Community Health 76, 960–966 (2022). URL https://jech.bmj.com/content/76/11/960. Publisher: BMJ Publishing Group Ltd Section: Glossary.
[17] Rosenbaum, P. R. & Rubin, D. B. The Central Role of the Propensity Score in Observational Studies for Causal Effects. Biometrika 70, 41–55 (1983). URL https://www.jstor.org/stable/2335942. Publisher: [Oxford University Press, Biometrika Trust].
[18] Stuart, E. A. Matching methods for causal inference: A review and a look forward. Statistical science : a review journal of the Institute of Mathematical Statistics 25, 1–21 (2010). URL https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943670/.
[19] Stel, V. S., Dekker, F. W., Zoccali, C. & Jager, K. J. Instrumental variable analysis. Nephrology Dialysis Transplantation 28, 1694–1699 (2013). URL https://doi.org/10.1093/ndt/gfs310.
[20] Glynn, A. N. & Quinn, K. M. An Introduction to the Augmented Inverse Propensity Weighted Estimator. Political Analysis 18, 36–56
(2010). URL https://www.cambridge.org/core/journals/political-analysis/article/an-introduction-to-the-augmented-inv erse-propensity-weighted-estimator/4B1B8301E46F4432C4DCC91FE20780DB. Publisher: Cambridge University Press.
[21] Chernozhukov, V. et al. Double/Debiased Machine Learning for Treatment and Causal Parameters (2017). URL http://arxiv.org/abs/1608.00060. ArXiv:1608.00060 [econ, stat].